Medpace Holdings

General Information
Business:

We are one of the world’s leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics. We differentiate ourselves from our competitors by our disciplined operating model centered on providing full-service Phase I-IV clinical development services and our therapeutic expertise.

Industry: COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees: 2300
Founded: 1992
Contact Information
Address 5375 Medpace Way, Cincinnati, OH 45227, US
Phone Number (513) 579-9911
Web Address http://www.medpace.com
View Prospectus: Medpace Holdings
Financial Information
Market Cap $911.7mil
Revenues $393.7 mil (last 12 months)
Net Income $-0.3 mil (last 12 months)
IPO Profile
Symbol MEDP
Exchange NASDAQ
Shares (millions): 7.0
Price range $23.00 - $23.00
Est. $ Volume $161.0 mil
Manager / Joint Managers Jefferies/ Credit Suisse/ UBS Investment Bank/ Wells Fargo Securities
CO-Managers Baird/ William Blair
Expected To Trade: 8/11/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change